Anti-IFN-γ treatment with monoclonal antibodies against IFN-γ improved the symptoms and survival rate of mice infected with the influenza virus because the neutralization of IFN-γ can reduce pulmonary hemorrhage and inflammatory cell infiltration [73]. Here, IFNG is linked to Pulmonary hemorrhage.